139 related articles for article (PubMed ID: 32631504)
1. Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
Sun W; Chen X; Huang S; Li W; Tian C; Yang S; Li L
Bioorg Med Chem Lett; 2020 Aug; 30(16):127215. PubMed ID: 32631504
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel and selective SIRT6 inhibitors.
Parenti MD; Grozio A; Bauer I; Galeno L; Damonte P; Millo E; Sociali G; Franceschi C; Ballestrero A; Bruzzone S; Del Rio A; Nencioni A
J Med Chem; 2014 Jun; 57(11):4796-804. PubMed ID: 24785705
[TBL] [Abstract][Full Text] [Related]
3. Cyclic peptide-based potent human SIRT6 inhibitors.
Liu J; Zheng W
Org Biomol Chem; 2016 Jul; 14(25):5928-35. PubMed ID: 27248480
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of 1-(2-Aminophenyl)-3-arylurea Derivatives as Potential EphA2 and HDAC Dual Inhibitors.
Zhu Y; Ran T; Chen X; Niu J; Zhao S; Lu T; Tang W
Chem Pharm Bull (Tokyo); 2016; 64(8):1136-41. PubMed ID: 27477652
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.
Chen X; Sun W; Huang S; Zhang H; Lin G; Li H; Qiao J; Li L; Yang S
J Med Chem; 2020 Sep; 63(18):10474-10495. PubMed ID: 32787077
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 1,3-Disubstituted 2,5-Diketopiperazine Derivatives as Potent Class I HDACs Inhibitors.
Gong G; Qi J; Lv Y; Dong S; Cao C; Li D; Zhao R; Li Z; Chen X
Chem Pharm Bull (Tokyo); 2020; 68(5):466-472. PubMed ID: 32378544
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
Marson CM; Matthews CJ; Yiannaki E; Atkinson SJ; Soden PE; Shukla L; Lamadema N; Thomas NS
J Med Chem; 2013 Aug; 56(15):6156-74. PubMed ID: 23829483
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development.
You W; Steegborn C
J Med Chem; 2018 Dec; 61(23):10922-10928. PubMed ID: 30395713
[TBL] [Abstract][Full Text] [Related]
9. Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities.
Chao SW; Chen LC; Yu CC; Liu CY; Lin TE; Guh JH; Wang CY; Chen CY; Hsu KC; Huang WJ
Eur J Med Chem; 2018 Jan; 143():792-805. PubMed ID: 29223096
[TBL] [Abstract][Full Text] [Related]
10. Cyclic tripeptide-based potent human SIRT7 inhibitors.
Li S; Wu B; Zheng W
Bioorg Med Chem Lett; 2019 Feb; 29(3):461-465. PubMed ID: 30578034
[TBL] [Abstract][Full Text] [Related]
11. Studying SIRT6 regulation using H3K56 based substrate and small molecules.
Kokkonen P; Rahnasto-Rilla M; Mellini P; Jarho E; Lahtela-Kakkonen M; Kokkola T
Eur J Pharm Sci; 2014 Oct; 63():71-6. PubMed ID: 25004411
[TBL] [Abstract][Full Text] [Related]
12. Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors.
Wang L; Li C; Chen W; Song C; Zhang X; Yang F; Wang C; Zhang Y; Qian S; Wang Z; Yang L
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357491
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
[TBL] [Abstract][Full Text] [Related]
14. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M
Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326
[TBL] [Abstract][Full Text] [Related]
15. Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors.
He B; Hu J; Zhang X; Lin H
Org Biomol Chem; 2014 Oct; 12(38):7498-502. PubMed ID: 25163004
[TBL] [Abstract][Full Text] [Related]
16. Natural polyphenols as sirtuin 6 modulators.
Rahnasto-Rilla M; Tyni J; Huovinen M; Jarho E; Kulikowicz T; Ravichandran S; A Bohr V; Ferrucci L; Lahtela-Kakkonen M; Moaddel R
Sci Rep; 2018 Mar; 8(1):4163. PubMed ID: 29515203
[TBL] [Abstract][Full Text] [Related]
17. Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors.
Nepali K; Chang TY; Lai MJ; Hsu KC; Yen Y; Lin TE; Lee SB; Liou JP
Eur J Med Chem; 2020 Jun; 196():112291. PubMed ID: 32325365
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy.
Yang Z; Shen M; Tang M; Zhang W; Cui X; Zhang Z; Pei H; Li Y; Hu M; Bai P; Chen L
Eur J Med Chem; 2019 Sep; 178():116-130. PubMed ID: 31177073
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
[TBL] [Abstract][Full Text] [Related]
20. Structural Insight into the Interactions between Structurally Similar Inhibitors and SIRT6.
Zhao S; Zhu YY; Wang XY; Liu YS; Sun YX; Zhao QJ; Li HY
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
